Details
Category: Volume 07 Issue 06 June 2019
Hits: 1101

Title: Cytological Pattern of Cervical Papanicolaou Smear According to 2014 Bethesda System: A Study Conducted in Tertiary Care Central India, Indore

Authors: Dr Sachin Sharma, Prof. Dr C.V. Kulkarni, Prof. Dr Meena Mittal, Dr Rakesh Mehar, Dr Ankesh Kumar Jain, Dr Priya Jain

 DOI: https://dx.doi.org/10.18535/jmscr/v7i6.113

Abstract

Introduction

Cervical cancer ranked second among most commonly diagnosed cancer and in less developed countries it is third leading cause of cancer related death among females[1,2,3]  It is estimated that each year, 527,000 new case occur and 275, 000 deaths. Globally, 15% of all cancer in females is cervical cancer.[2,4]. In India about 20% of all cancer related deaths is due to cervical cancer in women and is the number one cause of death in middle aged Indian women.[5] Also, India has 432.20 million women at risk for cervical cancer, annual number of cervical cancer cases is 122,844, annual number of deaths is 67, 4773.[6]

Cancer cervix is a multifactorial disease. Major risk factors are age[7,8], illiteracy, low socioeconomic status, early menarche, marital status, early marriage, early first childbirth, age at last child birth, multiparity, abortion, multiple sexual partners, late menopause, genital infection, poor genital hygiene, tobacco use, passive smoking and contraceptive use [9-13]. Other risk factors includes co-infection with Chlamydia trachomatis, non-use of condoms by partners and nutritional factors.[14-19]

Human Papilloma virus (HPV) infection is the most important risk factor.[20] It has been shown recently that cervical cancer is strongly associated with the presence of high risk or oncogenic Human Papilloma virus (HPV) types (up to 100%).[21,22]

Cervical cancer is a potentially a preventable disease through early detection using several screening techniques.[23] Therefore, the main focus is on the secondary prevention through early detection which is mainly done by cytology. This will lead to treatment of precancerous lesion itself before cancer develops hence reducing the incidence of cervical cancer.[24]  In Screening by cytology we look for pre- cancerous changes in the cervix that could develop into cervical cancer.[3] Cytomorphologically abnormal epithelial cells are best demonstrated by the Papanicolaou test. The initial and most important step in cervical cancer screening was the introduction of Papanicolaou (Pap) testing[25,26]. The 2014 Bethesda System has been introduced recently, which is used for reporting cervical smear in our study.

References

  1. Lindsey A. Torre; Freddie Bray; Rebecca L. Siegel; Jacques Ferlay; JoannieLortet-Tieulent; AhmedinJemal. Global Cancer Statistics, 2012. CA CANCER J CLIN 2015;65:87–108: 99-100.
  2. Bojgua S; Kldiashvili E. Liquid Based Cytology Cervical Cancer Screening Program – Georgian Experience. Arch Can Res. 2016, 4: 3.
  3. Ekane, G.E.H et al. (2015) Pap smear Screening, the Way Forward for Prevention of Cervical Cancer? A Community Based Study in the Buea Health District, Cameroon. Open Journal of Obstetrics and Gynecology, 5, 226-233.
  4. GakidouE;Nordhagen S; Obermeyer Z (2008) Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. Plos Med 5(6): e132. Doi:10.1371/journal. Pmed.0050132.
  5. BasuPartha; ChowdhuryDebjani. Cervical cancer screening & HPV vaccination: a comprehensive approach to cervical cancer control. Indian J Med Res 130, September 2009, pp 241-246.
  6. Naylor Bernard. The century for cytopathology. Actacytol 2000;44:709-725.
  7. Sánchez-Anguiano LF, Alvarado-Esquivel C, Reyes-Romero MA, Carrera- Rodríguez M. Human papilloma virus infections in women seeking cervical Papanicolaou cytology of Durango, Mexico: Prevalence and genotype. BMC Infec Dis 2006;6:27-33.
  8. García-Piñeres AJ, Hildesheim A, Herrero R, Trivett M, Williams M, Atmetlla I, et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res 2006;66:11070-6.
  9. Patil V, Wahab SN, Zodpey S, Vasudeo ND. Development and validation of risk scoring system for prediction of cancer cervix. Indian J Public Health 2006;50:38-42.
  10. Juneja A, Sehgal A, Mitra AB, Pandey A. A survey on risk factors associated with cervical cancer. Indian J Cancer. 2003 Jan- Mar;40:15-22.
  11. Mukherjee BN, Sengupta S, Chaudhuri S, Biswas LN, Maiti P.A. case-control study of reproductive risk factors associated with cervical cancer. Int J Cancer. 1994 Nov 15;59:476-82.
  12. Gawande V, Wahab SN, Zodpey SP, Vasudeo ND. Risk factors for cancer cervix: a case control study. Indian J Cancer. 1998;35:164-70.
  13. Aparajita Dasgupta, Narendra N Naskar, Rama Ram, Sila Deb A. Community Based Study On The Prevalence Of Risk Factors OF Cancer Cervix In Married Women Of A Rural Area Of West Bengal Year. Indian journal of community medicine 2002;27:35-38.
  14. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data on 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007;370:1609-21.
  15. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, et al. IARC Multi-centric Cervical Cancer Study Group. Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431-9.
  16. Richardson H, Abrahamowicz M, Tellier PP, Kelsall G, du Berger R, Ferenczy A, et al. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev 2005;14: 1149-56.
  17. Lai CH, Chao A, Chang CJ, Chao FY, Huang HJ, Hsueh S, et al. Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan. Int J Cancer 2008;123:1685-92.
  18. Tortolero-Luna G. Epidemiology of genital human papillomavirus. Hematol Oncol Clin North Am 1999;13:245-57.
  19. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, et al. High-risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101- 6.
  20. Schiffman M, Castle PE, Jeronim J, Rodrigue AC, Wacholde S. Human papillomavirus and cervical cancer.Lancet. 2007;370:890–907. [PubMed]
  21. Van den Brule AJC, Walboomers JMM, du Maine M, Kenemans P, Meijer CJLM. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991;48: 404-8.
  22. Resnick RM, Comelissen MTE, Wright DK, Eichinger GH, Fox HS, ter Schegget J, et al. Detection and typing of human papilloma virus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82:1477-84.
  23. Patil V, Wahab SN, Zodpey S, Vasudeo ND. Development and validation of risk scoring system for prediction of cancer cervix. Indian J Public Health 2006;50:38-42.
  24. Gupta P et al. Visual Inspection of the Cervix with Acetic Acid and Pap smear Test in Cervical Cancer Screening. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861.Vol 14, Issue 11 Ver. V (Nov. 2015), PP 38-4.
  25. Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Report on a workshop of the UICC project on Evaluation of Screening for Cancer. Int J Cancer 1990;46:761-9.
  26. Walton RJ. The task force on cervical cancer screening programs. Can Med Assoc J 1976;114:981
  27. Patel M.M., Pandya A.N., Modi J. — Cervical pap smear study and its utility in cancer screening, to specify the strategy for cervical cancer control. National Journal of Community Medicine; vol 2, issue1, 2011.
  28. Ghaith J.E., Rizwana B.S. — Rate of Opportunistic Pap smear Screening and Patterns of Epithelial Cell Abnormalities in Pap Smears in Ajman, United Arab Emirates. Sultan Qaboos Univ Med J; 12(4): 473–478, 2012.
  29. Khan MS, Raja FY, Ishfaq G, Tahir F, Subhan F, Kazi BM et al. Pap smear Screening for Precancerous conditions of the cervical cancers. Pak J. Med. Res.
  30. Edelman M, Fox A. Cervical Papanicolau smear abnormalities in inner Bronx adolescents: Prevalence, progression, and immune modifiers. Cancer (cancer cytopathology). 1999;87:184-9.
  31. Sunita A. Bamanikar, Dadaso S. Baravkar, Shirish S. Chandanwale, Prachet Dapkekar, Study of Cervical Pap Smears in a Tertiary Hospital, Indian Medical Gazette — JULY 2014
  32. Hemali J. Tailor, Patel R.D., Prashant R. Patel*, Vasudha M. Bhagat. Study of cervical pap smears in a tertiary care hospital of south Gujarat, India Tailor HJ et al. Int J Res Med Sci. 2016 Jan;4(1):286-288.
  33. Aikat, M., Gupta, S. & Aikat, B. K. Critical evaluation of cervical cytology. Indian J. Med. Res. 62, 655–661 (1974).
  34. Juneja, A. et al. Selective cervical cytology screening: discriminant analysis approach. Neoplasma 40, 401– 404 (1992).
  35. Manika AlexanderA, Ronald KhanapurB Study On Profile Of Patients Undergoing Pap Smear At A Tertiary Centre In Jabalpur, National Journal of Medical and Dental Research, July-September 2015: Volume-3, Issue-4, Page 206-212
  36. Selective screening forcancer of the cervix uteri in South Indian women. Shrivastav P, Jairaj P, Balasubramaniam N, Krishnaswami H. Abstract  Int J Gynaecol Obstet.  1986 Oct;24(5):337-42PMID:2880766
  37. Selectivecervical cytology screening: discriminant analysis approach. Juneja A1, Murthy NS, Sharma S, Shukla DK, Roy M, Das DK.  1993;40(6):401-4.PMID:8289972 Chronic cervicitis Etiology of cervical inflammation
  38. Cytologic screening for the detection ofcancer in the uterine cervix—a survey in Patna (India). Mishra NK, Sinha TK.Cancer Lett. 1990 Jun 30;52(1):21-7.PMID: 2354415
  39. Manika Alexander A, Ronald Khanapur B Study On Profile Of Patients Undergoing Pap Smear At A Tertiary Centre In Jabalpur, National Journal of Medical and Dental Research, July-September 2015: Volume-3, Issue-4, Page 206-212.

Corresponding Author

Dr Priya Jain